Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RCUS |
---|---|---|
09:32 ET | 16451 | 15.55 |
09:34 ET | 305 | 15.24 |
09:38 ET | 200 | 15.3 |
09:39 ET | 400 | 15.29 |
09:41 ET | 300 | 15.3 |
09:43 ET | 200 | 15.26 |
09:45 ET | 100 | 15.3 |
09:48 ET | 1547 | 15.36 |
09:50 ET | 405 | 15.33 |
09:52 ET | 100 | 15.37 |
09:56 ET | 1631 | 15.26 |
09:57 ET | 186 | 15.26 |
09:59 ET | 102 | 15.28 |
10:01 ET | 405 | 15.31 |
10:03 ET | 300 | 15.33 |
10:06 ET | 351 | 15.34 |
10:08 ET | 357 | 15.3 |
10:10 ET | 2067 | 15.36 |
10:12 ET | 500 | 15.39 |
10:14 ET | 1863 | 15.41 |
10:15 ET | 400 | 15.375 |
10:17 ET | 840 | 15.355 |
10:19 ET | 1254 | 15.36 |
10:21 ET | 1661 | 15.38 |
10:24 ET | 3410 | 15.416 |
10:26 ET | 1110 | 15.385 |
10:28 ET | 400 | 15.44 |
10:30 ET | 100 | 15.44 |
10:32 ET | 467 | 15.45 |
10:35 ET | 400 | 15.49 |
10:37 ET | 370 | 15.4455 |
10:39 ET | 611 | 15.49 |
10:42 ET | 100 | 15.5 |
10:44 ET | 4237 | 15.555 |
10:46 ET | 205 | 15.57 |
10:48 ET | 1100 | 15.58 |
10:50 ET | 1172 | 15.6 |
10:51 ET | 21402 | 15.635 |
10:53 ET | 1125 | 15.61 |
10:57 ET | 500 | 15.58 |
11:00 ET | 1301 | 15.5 |
11:02 ET | 1746 | 15.49 |
11:06 ET | 1803 | 15.55 |
11:08 ET | 51205 | 15.54 |
11:09 ET | 4663 | 15.525 |
11:13 ET | 1204 | 15.49 |
11:15 ET | 2361 | 15.48 |
11:18 ET | 2939 | 15.38 |
11:20 ET | 900 | 15.39 |
11:22 ET | 1462 | 15.34 |
11:24 ET | 1240 | 15.275 |
11:26 ET | 300 | 15.285 |
11:27 ET | 938 | 15.24 |
11:29 ET | 2719 | 15.1865 |
11:31 ET | 313 | 15.1953 |
11:36 ET | 314 | 15.24 |
11:38 ET | 610 | 15.26 |
11:40 ET | 946 | 15.25 |
11:42 ET | 557 | 15.26 |
11:44 ET | 100 | 15.265 |
11:45 ET | 4717 | 15.19 |
11:47 ET | 300 | 15.24 |
11:49 ET | 1219 | 15.21 |
11:51 ET | 413 | 15.22 |
11:54 ET | 400 | 15.23 |
11:58 ET | 442 | 15.23 |
12:00 ET | 400 | 15.245 |
12:02 ET | 2005 | 15.28 |
12:03 ET | 500 | 15.31 |
12:05 ET | 1323 | 15.27 |
12:07 ET | 711 | 15.27 |
12:09 ET | 881 | 15.29 |
12:12 ET | 500 | 15.29 |
12:14 ET | 300 | 15.29 |
12:16 ET | 554 | 15.33 |
12:18 ET | 684 | 15.295 |
12:20 ET | 400 | 15.28 |
12:21 ET | 1223 | 15.23 |
12:23 ET | 526 | 15.25 |
12:25 ET | 800 | 15.31 |
12:32 ET | 723 | 15.28 |
12:34 ET | 1552 | 15.325 |
12:36 ET | 2095 | 15.3 |
12:38 ET | 418 | 15.25 |
12:39 ET | 500 | 15.28 |
12:41 ET | 244 | 15.31 |
12:43 ET | 600 | 15.305 |
12:45 ET | 200 | 15.28 |
12:48 ET | 300 | 15.29 |
12:50 ET | 135 | 15.27 |
12:52 ET | 1032 | 15.28 |
12:54 ET | 431 | 15.3 |
12:56 ET | 602 | 15.29 |
12:59 ET | 891 | 15.2636 |
01:01 ET | 1938 | 15.32 |
01:03 ET | 1043 | 15.28 |
01:08 ET | 300 | 15.25 |
01:12 ET | 600 | 15.22 |
01:14 ET | 1115 | 15.215 |
01:15 ET | 400 | 15.21 |
01:17 ET | 200 | 15.215 |
01:21 ET | 1352 | 15.22 |
01:26 ET | 595 | 15.23 |
01:28 ET | 300 | 15.22 |
01:30 ET | 517 | 15.28 |
01:32 ET | 1000 | 15.25 |
01:33 ET | 200 | 15.26 |
01:37 ET | 300 | 15.25 |
01:39 ET | 484 | 15.28 |
01:42 ET | 200 | 15.29 |
01:44 ET | 300 | 15.29 |
01:46 ET | 531 | 15.28 |
01:48 ET | 312 | 15.29 |
01:50 ET | 608 | 15.32 |
01:53 ET | 489 | 15.33 |
01:55 ET | 282 | 15.33 |
01:57 ET | 1495 | 15.33 |
02:00 ET | 130 | 15.362 |
02:02 ET | 200 | 15.35 |
02:04 ET | 102 | 15.38 |
02:06 ET | 808 | 15.375 |
02:08 ET | 203 | 15.37 |
02:09 ET | 200 | 15.36 |
02:13 ET | 231 | 15.39 |
02:15 ET | 100 | 15.38 |
02:18 ET | 257 | 15.39 |
02:20 ET | 200 | 15.39 |
02:22 ET | 500 | 15.41 |
02:24 ET | 27731 | 15.37 |
02:26 ET | 100 | 15.355 |
02:27 ET | 542 | 15.34 |
02:29 ET | 886 | 15.27 |
02:31 ET | 304 | 15.27 |
02:33 ET | 507 | 15.29 |
02:36 ET | 300 | 15.3 |
02:38 ET | 700 | 15.32 |
02:40 ET | 1216 | 15.29 |
02:44 ET | 300 | 15.3 |
02:49 ET | 550 | 15.31 |
02:51 ET | 1750 | 15.284 |
02:54 ET | 3084 | 15.25 |
02:56 ET | 100 | 15.26 |
02:58 ET | 425 | 15.27 |
03:00 ET | 3304 | 15.26 |
03:02 ET | 700 | 15.25 |
03:03 ET | 100 | 15.26 |
03:05 ET | 686 | 15.265 |
03:07 ET | 3368 | 15.31 |
03:09 ET | 1295 | 15.3 |
03:12 ET | 100 | 15.31 |
03:14 ET | 321 | 15.31 |
03:16 ET | 800 | 15.31 |
03:18 ET | 3506 | 15.28 |
03:20 ET | 1197 | 15.28 |
03:21 ET | 1062 | 15.29 |
03:23 ET | 100 | 15.28 |
03:25 ET | 100 | 15.28 |
03:27 ET | 100 | 15.29 |
03:30 ET | 1270 | 15.29 |
03:32 ET | 1795 | 15.3 |
03:34 ET | 2760 | 15.275 |
03:36 ET | 1196 | 15.265 |
03:38 ET | 1507 | 15.29 |
03:39 ET | 1005 | 15.31 |
03:41 ET | 2974 | 15.305 |
03:43 ET | 955 | 15.31 |
03:45 ET | 2602 | 15.28 |
03:48 ET | 1502 | 15.29 |
03:50 ET | 1994 | 15.275 |
03:52 ET | 1706 | 15.26 |
03:54 ET | 4677 | 15.28 |
03:56 ET | 3130 | 15.305 |
03:57 ET | 6451 | 15.34 |
03:59 ET | 129522 | 15.39 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Arcus Biosciences Inc | 1.4B | -5.0x | --- |
WAVE Life Sciences Ltd | 1.2B | -15.2x | --- |
Ardelyx Inc | 1.6B | -24.9x | --- |
Nurix Therapeutics Inc | 1.4B | -7.5x | --- |
Gyre Therapeutics Inc | 1.1B | -13.7x | --- |
Xencor Inc | 1.4B | -6.7x | --- |
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $247.0M |
Shares Outstanding | 91.4M |
Arcus Biosciences Inc does not pay a dividend. | |
Beta | 0.89 |
EPS | $-3.10 |
Book Value | $6.12 |
P/E Ratio | -5.0x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -118.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.